WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index
The only company from pharmaceutical industry selected for inclusion in the Index Also included in HSI ESG Index and Hang Seng ESG 50 Index Green CRDMO solution provider with outstanding sustainability performance HONG KONG, Oct. 22, 2025...
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report
Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering positive impact to communities Accelerating actions for tackling climate change and...